文献速递糖尿病

2型糖尿病患者与健康对照肠道内胆囊收缩素及其受体的表达

Expression of Cholecystokinin and its Receptors in the Intestinal Tract of Type 2 Diabetes Patients and Healthy Controls.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

研究通过双气囊小肠镜在12例2型糖尿病患者与12例性别、年龄、BMI匹配的健康对照中按30 cm间隔取小肠黏膜活检并取大肠7个解剖部位,用mRNA测序和免疫组化分析CCK及其受体表达。结果显示CCK mRNA表达与CCK免疫反应细胞密度自十二指肠向回肠逐渐下降,大肠中极少,两组间无显著差异,两组十二指肠均可见CCK受体表达。

要点

  • CCK细胞密度与CCK mRNA表达自十二指肠向回肠逐渐下降,大肠中很低。
  • 2型糖尿病患者肠道黏膜CCK细胞密度与CCK mRNA表达未见改变。
  • 两组十二指肠均观察到CCK受体表达。

核心结论

  • 两组的CCK细胞密度与CCK mRNA表达沿小肠递减、在大肠处于低水平,2型糖尿病患者肠道黏膜的CCK细胞密度与CCK mRNA表达未发生改变。

研究设计与样本

  • 研究纳入12例2型糖尿病患者与12例按性别、年龄和体质指数匹配的健康个体。
  • 经双气囊小肠镜在小肠按30 cm间隔取黏膜活检,并在大肠7个解剖部位取样。
  • 采用mRNA测序与免疫组化染色分析CCK及CCK1、CCK2受体mRNA表达。

主要发现

  • CCK mRNA表达与CCK免疫反应细胞密度从十二指肠到回肠逐渐下降。
  • 大肠中CCK免疫反应细胞极少,CCK mRNA表达几乎检测不到。
  • 两组之间未见显著差异,两组十二指肠均观察到CCK受体表达。

临床怎么用

  • 人类I细胞主要分布于小肠近端并沿小肠递减的认识在本研究中得到印证,可支持以小肠为靶点评估CCK相关肠促胰素效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cholecystokinin (CCK) is a gut hormone originally known for its effects on gallbladder contraction and release of digestive enzymes. CCK, however, also mediates satiety and stimulate insulin secretion. Knowledge of the distribution of CCK-producing enteroendocrine cells (I cells) in humans is sparse. The general notion, based on animal data, is that I cells are present mainly in the proximal small intestine. We examined the occurrence of I cells (immunohistochemically) and the expression of CCK messenger RNA (mRNA) as well as CCK1 and CCK2 receptor mRNA along the intestines in healthy individuals and patients with type 2 diabetes. METHODS: Mucosal biopsies collected with 30-cm intervals in the small intestine and from seven anatomical locations in the large intestine (using double-balloon enteroscopy) from 12 patients with type 2 diabetes and 12 gender-, age-, and body mass index-matched healthy individuals were analyzed using mRNA sequencing and immunohistochemical staining. RESULTS: We observed a gradual decrease in CCK mRNA expression and density of CCK-immunoreactive cells from duodenum to ileum. Very few CCK-immunoreactive cells and nearly undetectable CCK mRNA expression were found in the large intestine. No significant differences were seen between the groups. Expression of CCK receptors was observed in the duodenum of both groups. CONCLUSIONS: Both density of CCK cells and expression of CCK mRNA decreased through the small intestine in both groups with low levels in the large intestine. Patients with type 2 diabetes did not have altered density of CCK cells or expression of CCK mRNA in intestinal mucosa.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Gilliam-Vigh H, Jorsal T, Rehfeld JF, et al. Expression of Cholecystokinin and its Receptors in the Intestinal Tract of Type 2 Diabetes Patients and Healthy Controls. J Clin Endocrinol Metab. 2021. PMID: 34036343. doi:10.1210/clinem/dgab367

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。